Estrogen and selective estrogen receptor modulator regulation of insulin-like growth factor binding protein 5 in the rat uterus

References

• Rajaram S, Baylink DJ, Mohan S. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev 1997;18:801–31
   Google Scholar
• Baxter RC, Martin JL. Binding proteins for the insulin-like growth factors: structure, regulation and function. Prog Growth Factor Res 1989;1:49–68
   PubMedGoogle Scholar
• Rechler MM. Insulin-like growth factor binding proteins. Vitam Horm 1993;47:1–114
   PubMed Web of Science ®Google Scholar
• Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995;16:3–34
   PubMed Web of Science ®Google Scholar
• Rosenfeld RG, Lamson G, Pham H, etal. Insulin-like growth factor-binding proteins. Recent Prog Horm Res 1990;46:99–159
   PubMedGoogle Scholar
• Rutanen EM. Insulin-like growth factor and insulin-like growth factor-binding proteins in the endometrium. Effects of intrauterine levonor-gestrel delivery. Hum Reprod 2000;15:173–81
   Google Scholar
• Adesanya 00, Zhou J, Bondy CA. Cellular localization and sex steroid regulation of insulin-like growth factor binding protein messen-ger ribonucleic acids in the primate myometrium. J Clin Endocrinol Metab 1996;81:2495–501
   Google Scholar
• Rutanen EM, Pekonen F, Makinen T. Soluble 34K binding protein inhibits the binding of insulin-like growth factor I to its cell receptors in human secretory phase endometrium: evidence for autocrine/paracrine regulation of growth factor action. J Clin Endocrinol Metab 1988;66: 173–80
   Google Scholar
• Andrade PM, Baracat EC, Simoes MJ, etal. Histo-morphometric aspects of adult castrated rat endo-metrium after the use o f estro gen, progesterone and tamoxifen. Clin Exp Obstet Gynecol 2000;27: 138–41
   PubMedGoogle Scholar
• Wang HS, Wang TH, Soong YK. Elevation of insulin-like growth factor-binding protein-1 niRNA expression following replacement therapy. Hum Reprod 2000;16: 50–4
   Google Scholar
• Zhou J, Dsupin BA, Giudice LC, etal. Insulin-like growth factor system gene expression in human endometrium during the menstrual cycle. J Clin Endocrinol Metab 1994;79:1723–34
   PubMed Web of Science ®Google Scholar
• Mohan S, Nakao Y, Honda Y. Studies on the mechanisms by which insulin-like growth factor- binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J Biol Chem 1995;270: 20424–31
   Google Scholar
• Burger HG. Selective oestrogen receptor modula-tors. Horm Res 2000;53:25–9
   PubMedGoogle Scholar
• Jordan VC, Adashi EY, Rock JA, et al. Estrogen receptor antagonist. In Reproductive Endocrinology, Surgery, and Technology. Philadelphia: Lippincott Raven, 1996:524
   Google Scholar
• Lerner 14, Jordan VC. Development of anti-estrogens and their use in breast cancer. Cancer Res 1990;50:4177–83
   PubMedGoogle Scholar
• Chen JC, Shao ZM, Sheikh MS, et al. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I) mediated DNA synthesis and IGF-I binding in human breast carcinoma cell line. J Cell Physiol 1994;158:69–78
   PubMedGoogle Scholar
• Oh YM, Muller HL, Lamson G, et al. Insulin-like growth factor (IGF)-independent action of IGF- binding protein-3 in Hs578T human breast cancer cells — cell surface binding and growth inhibition. Biochem Biophys Res Commun 1993;198:292–7
   Google Scholar
• Kleinman D, Karas M, Danilenko M, et al. Stimula-tion of endometrial cancer cell growth by tamoxifen is associated with increased insulin-like growth factor (IGF)-I induced tyrosine phos-pho rylatio n and reduction in IGF binding proteins. Endocrinology 1996;137:1089–95
   PubMedGoogle Scholar
• Canadian Council on Animal Care. Guide to the Care and Use of Experimental Animals, volI and II. Ottawa: Canadian Council on Animal Care, 1984
   Google Scholar
• Baracat EC, Simoes MJ. Standardization of the dose-effect of oral estrogen and progestogen in adult rats. Ninth Annual Meeting of the North American Menopause Society, 1998:p70
   Google Scholar
• Niwa K, Morishita S, Hashimoto M, et al. Effects of tamoxifen on endometrial carcinogenesis in mice. Jpn J Cancer Res 1998;86:502–9
   Google Scholar
• Evans G, Bryant HU, Magee D, et al. The effects of raloxifene on tibia histomorphometry in ovari-ectomized rats. Endocrinology 1993;134:2283–8
   Google Scholar
• Karlsson S, Hirsimaki Y, Mantyla E, et al. A two-year dietary carcinogenicity study of the anti-estrogen toremifene in Sprague—Dawley rats. Drug Chem Toxicol 1996;19:245–66
   PubMed Web of Science ®Google Scholar
• Tokunaga K, Nakamura Y, Sakata K, et al. Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res 1987;47:5616–19
   PubMed Web of Science ®Google Scholar
• Clemmons DR. IGF binding proteins: regulations of cellular actions. Growth Regul 1992;2:80–7
   PubMedGoogle Scholar
• Huynh H. Suppression of uterine insulin-like growth factor binding protein 5 by estrogen is mediated in part by insulin-like growth factor I. Int J Oncol 1998;12:427–32
   PubMedGoogle Scholar
• Conover CA. Regulation and physiological role of insulin-like growth factor binding proteins. Endocr J1996;43:43–8
   Google Scholar
• Schedlich 14, Young TF, Firth SM, et al. Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport T47D human breast carcinoma cells 1998;273:18347-52
   Google Scholar
• Tomis El, Voutilainen RJ. The of insulin-like growth factor and its binding protein mRNA in the endometrium of postmenopausal patients with breast cancer receiv-ing tamoxifen. Cancer 1995;76: 1406–10
   Google Scholar
• Gloudemans T, Pospiech I, Van der Ven LT, et al. An avail restriction fragment length polymorphism in the insulin-like growth factor II gene and the occurrence of smooth muscle tumors. Cancer Res 1993;53:5754–8
   Google Scholar
• Girvigian MR, Nakatani A, Ling N, et al. Insulin-like growth factor binding proteins show distinct patterns of expression in the rat uterus. Biol Reprod 1994;51:296–302
   PubMedGoogle Scholar
• Hung H, Pollak M. Regulation of IGFBP-3 expression in breast cancer cells and uterus by estradiol and antiestrogens: correlations with effects on proliferation: a review. Prog Growth Factor Res 1995;6:495–501
   PubMedGoogle Scholar
• Giudice LC, Irwin JC, Dsupin BA, et al. Insulin-like growth factor (IGF), IGF binding protein (IGFBP), and IGF receptor gene expression and IGFBP synthesis in human uterine leiomyomata. Hum Reprod 1993;8:1796-806 pathway inJ Biol Chem 29. Laatikainen expression
   Google Scholar